MarketPeel
Insider Trading Intelligence
EL

Ecor1 Capital, Llc

NUVB
DIRECTOR · NUVATION BIO INC. · CIK 0001587114
FILING MIX · LIFETIME83%/17%
BUYS
115
SELLS
23
TOTAL VALUE
$686.47M
COMPANIES
10
ACTIVE SINCE
Feb 2021
HOLDINGS NOW
46,292,428
AVG SELL PX
$8.23
TRADE KIND
SHOWING 138 / 138
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
109 backtested trades · 8 horizons · 61 pending
Forward-return performance of every backtestable P/S trade by Ecor1 Capital, Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d109+48.62%+1.88%-0.02%+1.90%+0.48%2.11
14d109+48.62%+1.97%+0.01%+2.02%+0.88%1.98
30d109+61.47%+0.86%+1.35%-0.40%+1.27%-0.32
60d109(1 pending)+50.00%+0.19%+2.72%-2.53%-6.01%-1.91
90d109(2 pending)+45.79%-1.95%+4.01%-5.96%-5.99%-3.58
180d109(4 pending)+54.29%+22.96%+9.94%+13.02%+5.44%2.49
1y109(4 pending)+71.43%+49.86%+15.08%+34.79%+43.37%5.80
2y109(50 pending)+64.41%+19.38%+23.07%-3.69%-11.88%-0.39
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NUVB · 12,674,775 shares · as of Sep 21, 2023
03,168,6946,337,3889,506,08112,674,77520222023SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 115 buys / 23 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ATRA
ATARA BIOTHERAPEUTICS, INC.
PURCHASE
507,407$9.35$4.74M1,552,000May 7, 2026May 11, 2026View →
TRAX
FIRST TRACKS BIOTHERAPEUTICS, INC.
PURCHASE
4,705,575$13.81$65.00M3,174,519Apr 20, 2026Apr 22, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
2,270,8792,270,879Jan 12, 2026Jan 12, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
128,506128,506Jan 12, 2026Jan 12, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
86,22286,222Jan 12, 2026Jan 12, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
9,913,8100Jan 12, 2026Jan 12, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
2,077,779$18.00$37.40M4,348,658Jan 12, 2026Jan 12, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
202,862202,862Jan 12, 2026Jan 12, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
488,8910Jan 12, 2026Jan 12, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
102,5000Jan 12, 2026Jan 12, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
965,190965,190Jan 12, 2026Jan 12, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
PURCHASE
144,443$18.00$2.60M347,305Jan 12, 2026Jan 12, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
2,397,5000Jan 12, 2026Jan 12, 2026View →
AKTS
AKTIS ONCOLOGY, INC.
SALE
997,2990Jan 12, 2026Jan 12, 2026View →
ZYME
ZYMEWORKS INC.
SALE
41$12.71$52122,970,388Jun 26, 2025Jun 27, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
5,086,480$0.00$50922,970,388Jun 26, 2025Jun 27, 2025View →
ZYME
ZYMEWORKS INC.
SALE
5,086,5210Jun 26, 2025Jun 27, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
5,919$11.78$69.7K17,883,908May 19, 2025May 19, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
49,502$11.43$565.8K17,877,989May 15, 2025May 19, 2025View →
PRTA
PROTHENA CORP PUBLIC LTD CO
SALE
1,984,053$7.64$15.16M5,304,596May 6, 2025May 6, 2025View →
PRTA
PROTHENA CORP PUBLIC LTD CO
SALE
977,693$8.11$7.93M7,288,649May 5, 2025May 6, 2025View →
PRTA
PROTHENA CORP PUBLIC LTD CO
SALE
3,317,938$8.36$27.74M8,266,342May 2, 2025May 6, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
54,760$11.52$630.8K17,828,487Apr 17, 2025Apr 18, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
73,953$11.16$825.6K17,773,727Apr 16, 2025Apr 18, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
196,438$11.17$2.19M17,699,774Apr 4, 2025Apr 7, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
120,770$11.84$1.43M17,503,336Apr 3, 2025Apr 7, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
74,360$11.85$881.0K17,382,566Apr 2, 2025Apr 2, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
48,658$11.60$564.6K17,308,206Apr 1, 2025Apr 2, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
4,397$11.75$51.7K17,259,548Mar 31, 2025Apr 2, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
43,848$12.24$536.9K17,255,151Mar 26, 2025Mar 26, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
53,501$12.91$690.5K17,211,303Mar 25, 2025Mar 26, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
22,689$13.08$296.8K17,157,802Mar 24, 2025Mar 24, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
31,033$12.78$396.5K17,135,113Mar 21, 2025Mar 24, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
73,476$12.93$949.9K17,104,080Mar 20, 2025Mar 24, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
58,306$12.64$737.2K17,030,604Mar 19, 2025Mar 19, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
113,880$12.65$1.44M16,972,298Mar 18, 2025Mar 19, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
56,277$12.23$688.5K16,858,418Mar 17, 2025Mar 19, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
468,356$12.48$5.85M16,802,141Mar 13, 2025Mar 13, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
292,934$12.25$3.59M16,333,785Mar 12, 2025Mar 13, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
320,690$11.49$3.69M16,040,851Mar 11, 2025Mar 13, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
19,748$13.87$274.0K15,720,161Jan 17, 2025Jan 21, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
121,681$13.89$1.69M15,700,413Jan 16, 2025Jan 21, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
39,029$14.01$546.7K15,578,732Jan 15, 2025Jan 15, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
54,500$13.56$739.3K15,539,703Jan 14, 2025Jan 15, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
74,125$13.39$992.9K15,485,203Jan 13, 2025Jan 15, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
204,098$13.13$2.68M15,411,078Jan 10, 2025Jan 10, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
21,021$14.07$295.8K15,206,980Jan 8, 2025Jan 10, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
157,880$14.78$2.33M15,185,959Jan 2, 2025Jan 2, 2025View →
ANAB
ANAPTYSBIO, INC
PURCHASE
6,646$12.95$86.1K7,880,094Jan 2, 2025Jan 2, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
146,501$14.57$2.13M15,028,079Dec 31, 2024Jan 2, 2025View →
ANAB
ANAPTYSBIO, INC
PURCHASE
13,268$12.93$171.5K7,873,448Dec 31, 2024Jan 2, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
58,988$14.47$853.3K14,881,578Dec 30, 2024Jan 2, 2025View →
ANAB
ANAPTYSBIO, INC
PURCHASE
65,184$12.92$842.1K7,860,180Dec 30, 2024Jan 2, 2025View →
ZYME
ZYMEWORKS INC.
PURCHASE
101,659$14.49$1.47M14,822,590Dec 27, 2024Dec 27, 2024View →
ZYME
ZYMEWORKS INC.
PURCHASE
16,692$14.38$240.0K14,720,931Dec 26, 2024Dec 27, 2024View →
ZYME
ZYMEWORKS INC.
PURCHASE
11,958$14.12$168.9K14,704,239Dec 24, 2024Dec 27, 2024View →
ZYME
ZYMEWORKS INC.
PURCHASE
251,502$14.25$3.58M14,692,281Dec 23, 2024Dec 24, 2024View →
ZYME
ZYMEWORKS INC.
PURCHASE
704,488$14.08$9.92M14,440,779Dec 20, 2024Dec 24, 2024View →
ZYME
ZYMEWORKS INC.
PURCHASE
298,818$13.53$4.04M13,736,291Dec 19, 2024Dec 24, 2024View →
TNGX
TANGO THERAPEUTICS, INC.
SALE
1,143,124$2.92$3.33M10,630,736Nov 7, 2024Nov 8, 2024View →
TNGX
TANGO THERAPEUTICS, INC.
SALE
62,318$3.29$205.1K11,773,860Nov 7, 2024Nov 8, 2024View →
TNGX
TANGO THERAPEUTICS, INC.
SALE
1,494,558$3.28$4.90M11,836,178Nov 6, 2024Nov 8, 2024View →
ANAB
ANAPTYSBIO, INC
PURCHASE
273,972$36.50$10.00M7,794,996Aug 14, 2024Aug 15, 2024View →
ZYME
ZYMEWORKS INC.
PURCHASE
5,086,521$9.83$50.00M5,086,521Dec 26, 2023Dec 28, 2023View →
ZYME
ZYMEWORKS INC.
PURCHASE
5,086,521$9.83$50.00M5,086,521Dec 26, 2023Dec 28, 2023View →
NUVB
NUVATION BIO INC.
PURCHASE
53,000$1.36$72.1K12,674,775Sep 21, 2023Sep 22, 2023View →
NUVB
NUVATION BIO INC.
PURCHASE
117,100$1.36$159.5K12,621,775Sep 20, 2023Sep 22, 2023View →
NUVB
NUVATION BIO INC.
PURCHASE
5,143,000$1.26$6.46M12,504,675Sep 19, 2023Sep 22, 2023View →
ZYME
ZYMEWORKS INC.
PURCHASE
3,350,000$8.12$27.20M13,437,473Jun 16, 2023Jun 21, 2023View →
ZYME
ZYMEWORKS INC.
PURCHASE
200,000$8.00$1.60M10,087,473Mar 28, 2023Mar 30, 2023View →
NUVB
NUVATION BIO INC.
PURCHASE
53,000$1.36$72.1K12,674,775Feb 21, 2023Sep 21, 2023View →
NUVB
NUVATION BIO INC.
PURCHASE
117,100$1.36$159.5K12,621,775Feb 20, 2023Sep 21, 2023View →
NUVB
NUVATION BIO INC.
PURCHASE
5,143,000$1.26$6.46M12,504,675Feb 19, 2023Sep 21, 2023View →
ZYME
ZYMEWORKS INC.
PURCHASE
163,400$9.88$1.62M9,887,473Jan 20, 2023Jan 23, 2023View →
ZYME
ZYMEWORKS INC.
PURCHASE
144,100$9.49$1.37M9,724,073Jan 19, 2023Jan 23, 2023View →
ZYME
ZYMEWORKS INC.
PURCHASE
203,000$10.00$2.03M9,579,973Jan 18, 2023Jan 18, 2023View →
ZYME
ZYMEWORKS INC.
PURCHASE
440,000$9.80$4.31M9,376,973Jan 17, 2023Jan 18, 2023View →
ZYME
ZYMEWORKS INC.
PURCHASE
342,100$9.81$3.35M8,936,973Jan 13, 2023Jan 18, 2023View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
110,000$8.50$934.6K3,851,507Jan 11, 2023Jan 11, 2023View →
ZYME
ZYMEWORKS INC.
PURCHASE
106,300$7.87$836.9K8,594,873Jan 11, 2023Jan 12, 2023View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
336,400$8.05$2.71M3,961,507Jan 10, 2023Jan 11, 2023View →
ZYME
ZYMEWORKS INC.
PURCHASE
920,000$7.65$7.04M8,488,573Jan 10, 2023Jan 12, 2023View →
VYGR
VOYAGER THERAPEUTICS, INC.
SALE
456,000$7.67$3.50M4,297,907Jan 9, 2023Jan 11, 2023View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASE
376,000$5.66$2.13M4,753,907Jun 23, 2022Jun 23, 2022View →
VYGR
VOYAGER THERAPEUTICS, INC.
PURCHASE
101,400$5.28$535.5K4,377,907Jun 21, 2022Jun 23, 2022View →
PRTA
PROTHENA CORP PUBLIC LTD CO
PURCHASE
1,062,736$29.02$30.84M11,584,280May 5, 2022May 6, 2022View →
PRTA
PROTHENA CORP PUBLIC LTD CO
SALE
1,062,736$29.02$30.84M11,584,280May 5, 2022May 6, 2022View →
ANAB
ANAPTYSBIO, INC
SALE
668,237$21.63$14.45M7,521,024May 5, 2022May 6, 2022View →
ANAB
ANAPTYSBIO, INC
PURCHASE
668,237$21.63$14.45M7,521,024May 5, 2022May 6, 2022View →
PRTA
PROTHENA CORP PUBLIC LTD CO
PURCHASE
300,000$37.50$11.25M11,584,280Jan 12, 2022Jan 12, 2022View →
NUVB
NUVATION BIO INC.
PURCHASE
163,268$7.69$1.25M7,361,675Nov 24, 2021Nov 30, 2021View →
NUVB
NUVATION BIO INC.
PURCHASE
21,758$7.69$167.2K1,169,241Nov 24, 2021Nov 30, 2021View →
CRVS
CORVUS PHARMACEUTICALS, INC.
SALE
2,000,000$4.96$9.93M81,077Oct 1, 2021Oct 1, 2021View →
CRVS
CORVUS PHARMACEUTICALS, INC.
SALE
3,000,000$5.04$15.13M2,081,077Sep 30, 2021Oct 1, 2021View →
NUVB
NUVATION BIO INC.
PURCHASE
56,598$8.64$489.0K7,198,407Jul 31, 2021Nov 30, 2021View →
NUVB
NUVATION BIO INC.
SALE
56,598$8.64$489.0K1,147,483Jul 31, 2021Nov 30, 2021View →
PRTA
PROTHENA CORP PUBLIC LTD CO
SALE
2,5000Jun 18, 2021Jun 22, 2021View →
PRTA
PROTHENA CORP PUBLIC LTD CO
PURCHASE
250,000$30.00$7.50M11,284,280Jun 18, 2021Jun 22, 2021View →
ANAB
ANAPTYSBIO, INC
PURCHASE
165,000$23.25$3.84M7,520,424May 4, 2021May 4, 2021View →
ANAB
ANAPTYSBIO, INC
PURCHASE
20,800$23.31$484.9K7,355,424May 3, 2021May 4, 2021View →
ANAB
ANAPTYSBIO, INC
PURCHASE
35,700$23.16$826.8K7,334,624Apr 30, 2021May 4, 2021View →
ANAB
ANAPTYSBIO, INC
PURCHASE
33,800$23.82$805.1K7,298,924Apr 27, 2021Apr 27, 2021View →
ANAB
ANAPTYSBIO, INC
PURCHASE
13,900$23.80$330.9K7,265,124Apr 26, 2021Apr 27, 2021View →
ANAB
ANAPTYSBIO, INC
PURCHASE
99,600$23.54$2.34M7,251,224Apr 23, 2021Apr 27, 2021View →
NUVB
NUVATION BIO INC.
PURCHASE
27,534$10.27$282.8K6,990,265Apr 13, 2021Apr 13, 2021View →
NUVB
NUVATION BIO INC.
PURCHASE
3,966$10.27$40.7K1,355,625Apr 13, 2021Apr 13, 2021View →
NUVB
NUVATION BIO INC.
PURCHASE
116,255$9.49$1.10M6,962,731Apr 12, 2021Apr 13, 2021View →
NUVB
NUVATION BIO INC.
PURCHASE
16,745$9.49$158.9K1,351,659Apr 12, 2021Apr 13, 2021View →
NUVB
NUVATION BIO INC.
PURCHASE
37,770$10.03$378.9K1,334,914Apr 9, 2021Apr 13, 2021View →
NUVB
NUVATION BIO INC.
PURCHASE
262,230$10.03$2.63M6,846,476Apr 9, 2021Apr 13, 2021View →
NUVB
NUVATION BIO INC.
PURCHASE
151,544$10.45$1.58M1,145,600Mar 31, 2021Nov 30, 2021View →
NUVB
NUVATION BIO INC.
PURCHASE
151,544$10.45$1.58M6,735,790Mar 31, 2021Nov 30, 2021View →
PRTA
PROTHENA CORP PUBLIC LTD CO
PURCHASE
875,000$20.75$18.16M11,034,280Mar 24, 2021Mar 25, 2021View →
ANAB
ANAPTYSBIO, INC
PURCHASE
531,000$18.70$9.93M7,151,624Mar 9, 2021Mar 10, 2021View →
ANAB
ANAPTYSBIO, INC
PURCHASE
2,777,800$18.97$52.69M6,620,624Mar 8, 2021Mar 10, 2021View →
PRTA
PROTHENA CORP PUBLIC LTD CO
PURCHASE
10,800$22.02$237.9K10,159,280Feb 24, 2021Feb 25, 2021View →
ANAB
ANAPTYSBIO, INC
PURCHASE
29,500$25.48$751.7K3,842,824Feb 23, 2021Feb 25, 2021View →
PRTA
PROTHENA CORP PUBLIC LTD CO
PURCHASE
44,400$21.05$934.5K10,148,480Feb 23, 2021Feb 25, 2021View →
PRTA
PROTHENA CORP PUBLIC LTD CO
PURCHASE
44,100$3.68$162.1K10,104,080Feb 18, 2021Feb 22, 2021View →
PRTA
PROTHENA CORP PUBLIC LTD CO
PURCHASE
44,100$23.65$1.04M10,104,080Feb 18, 2021Feb 23, 2021View →
PRTA
PROTHENA CORP PUBLIC LTD CO
PURCHASE
2,500$3.68$9.2K2,500Feb 17, 2021Feb 26, 2021View →
PRTA
PROTHENA CORP PUBLIC LTD CO
PURCHASE
2,500$3.68$9.2K2,500Feb 17, 2021Feb 17, 2021View →
PRTA
PROTHENA CORP PUBLIC LTD CO
PURCHASE
198,840$23.46$4.67M10,059,980Feb 17, 2021Feb 17, 2021View →
PRTA
PROTHENA CORP PUBLIC LTD CO
PURCHASE
89,200$22.78$2.03M9,861,140Feb 16, 2021Feb 17, 2021View →
PRTA
PROTHENA CORP PUBLIC LTD CO
PURCHASE
282,800$20.08$5.68M9,771,940Feb 12, 2021Feb 17, 2021View →
PRTA
PROTHENA CORP PUBLIC LTD CO
PURCHASE
62,500$20.50$1.28M9,489,140Feb 12, 2021Feb 17, 2021View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
2,365,5116,584,246Feb 10, 2021Feb 12, 2021View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
394,000394,000Feb 10, 2021Feb 12, 2021View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
130,000130,000Feb 10, 2021Feb 12, 2021View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
131,333131,333Feb 10, 2021Feb 12, 2021View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
387,265$10.00$3.87M781,265Feb 10, 2021Feb 12, 2021View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
2,112,735$10.00$21.13M4,218,735Feb 10, 2021Feb 12, 2021View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
702,000702,000Feb 10, 2021Feb 12, 2021View →
NUVB
NUVATION BIO INC.
SALE
2,775,0000Feb 10, 2021Feb 12, 2021View →
NUVB
NUVATION BIO INC.
PURCHASE
2,775,0003,165,000Feb 10, 2021Feb 12, 2021View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
515,8791,297,144Feb 10, 2021Feb 12, 2021View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
2,106,0002,106,000Feb 10, 2021Feb 12, 2021View →
NUVB
NUVATION BIO INC.
PURCHASEGRANT
Stock grant
2,200,6272,200,627Feb 10, 2021Feb 12, 2021View →
Other insiders · NUVB
Loading peer insiders…
About this filer
CIK 0001587114
ROLE
Director
PRIMARY
NUVB
COMPANIES
10
ACTIVE SINCE
Feb 2021
MARKETPEEL · /INSIDER/0001587114DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback